U.S. Banking Agencies Propose Sweeping Overhaul of Capital Framework - Part IV: Foreign Banking Organizations

Applicability to FBOs: Where, How, and on What Timeline

IHCs must apply revised Part 217 like U.S. BHCs. The Federal Reserve proposes explicit Regulation YY text stating that a U.S. intermediate holding company "must comply with 12 CFR part 217 in the same manner as a bank holding company," applying the capital-rule revisions wholesale to IHCs. The proposal also updates Part 252 definitions for covered IHC total-loss absorbing capacity ("TLAC")/long-term debt ("LTD") to reference "standardized total risk‑weighted assets or expanded total risk‑weighted assets, as applicable under part 217." This means that IHCs will have to recalculate applicable capital ratios and any internal TLAC measures that depend on total RWA under the new rules, if finalized.

ERBA mandate, opt‑in, and single‑stack mechanics. The ERBA is mandatory for Category I–II organizations; other banking organizations, including IHCs, may elect ERBA in its entirety with written notice and a 12‑month waiting period. For FBO IHCs considering an opt‑in, the key reference points are the ERBA's aggregate impact on Category I–II firms: credit RWA falls 10.0% (from $680 billion to $612 billion), but operational risk RWA rises 14.9% and CVA RWA nearly doubles (+96.0%), for a net total RWA decrease of 4.8%. The agencies estimate that three Category III or IV holding companies would see CET1 reductions of 3–7% by electing ERBA, and roughly one‑third of sub‑Category IV firms would see reductions of 5–10%, making the opt‑in analysis portfolio‑specific and consequential for IHCs weighing the trade‑offs. Any decision regarding the opt-in or out election should be based on a bank's individual circumstances.

Estimated CET1 Impact for FBO IHCs. The net –5.2% CET1 impact estimated by the agencies reflects lower standardized risk weights (–6.1%), offset by mandatory AOCI recognition (+3.1%), plus reduced stress test requirements (–2.2%). For comparison, Category I–II firms should see a –4.8% (~$42.1 billion) reduction driven by ERBA (+1.4%), GSIB surcharge (–3.8%), and stress test changes (–2.4%). Comments are due June 18, 2026.

Standardized Approach Changes Most Relevant to FBO IHCs

AOCI recognition for Category III–IV IHCs. For FBO IHCs that previously opted out of AOCI, this is the single most consequential capital‑numerator change. The standardized‑approach proposal requires Category III–IV organizations to include most AOCI elements in CET1, phased in over five years beginning January 1, 2027, with full recognition required by January 1, 2032. The agencies estimate the AOCI change increases capital requirements by about 3.1 percentage points on a long‑run average, partially offsetting RWA reductions.

Standardized risk‑weight recalibrations. Key changes to IHC RWAs include: corporate exposures dropping from 100% to 95% (–7.0% RWA), "other assets" from 100% to 90% (–10.0% RWA) , and residential mortgages shifting from the flat 50% first‑lien weight to LTV‑based bands of 25%–75% (non‑cash‑flow) and 35%–110% (cash‑flow‑dependent), yielding an estimated –30.4% residential mortgage RWA reduction for holding companies. The threshold‑based CET1 deduction for mortgage servicing assets is eliminated in favor of a flat 250% risk weight.

Treatment of exposures to foreign banks. This is disproportionately relevant to FBO IHCs with affiliate or correspondent interbank exposures. Under ERBA, the bank‑exposure framework introduces granular grades, including a sovereign‑based risk‑weight floor where currency convertibility/transfer risk could impede applicable payments. Short‑term self‑liquidating trade‑related contingent items may receive preferential risk weights, which matters for IHC trade finance books. IHCs should map interbank portfolios against the new grading criteria to assess RWA effects.

Trading Activity, Market Risk, and CVA: Triggers for IHCs

Market‑risk capital applies to any banking organization, including an IHC, with trading assets and liabilities of at least 10% of total assets or $5 billion on a four‑quarter average, with the $5 billion threshold indexed for inflation. CVA requirements apply where market‑risk capital is in scope and OTC derivatives gross notional averages at least $1 trillion over four quarters. The proposals retain reservation‑of‑authority language that permits supervisors to adjust scope based on risk profiles. For IHCs with U.S. broker‑dealer subsidiaries, these thresholds should inform the ERBA opt‑in analysis—particularly given the 96% CVA RWA increase observed in Category I–II data.

FR Y‑15 and Category Determinations for FBOs

The Board proposes to eliminate FBO‑specific Schedules H–N and require FBOs to file Schedules A–G for combined U.S. operations and separately for any IHC, effective two calendar quarters after adoption. FR Y‑15 data continue to drive prudential category determinations for FBOs with at least $100 billion in combined U.S. assets, with systemic indicators shifting from point‑in‑time to average‑based measurement. While the GSIB surcharge itself does not apply to IHCs, the surcharge recalibration—reducing average surcharges from 2.7% to ~2.3% (–$23 billion in the aggregate)—affects the FR Y‑15 indicator methodologies that are operationally significant for FBO category determinations and M&A analytics.

Covered IHC TLAC/LTD and SCCL

Covered IHC TLAC and LTD requirements will now reference "standardized total risk‑weighted assets or expanded total risk‑weighted assets," which aligns loss‑absorbing capacity metrics with the revised capital rules. For context, the combined proposals reduce aggregate GSIB TLAC requirements by ~$46 billion (–2.6%, from ~$1.79 trillion baseline) and LTD requirements by ~$17 billion (–2.3%), with requirements projected to decrease for five GSIBs and increase for one. Conforming updates to SCCL currency‑mismatch cross‑references do not change calibration but require policy and systems alignment with relocated Part 217 provisions.

National Treatment and Cross‑Border Considerations

The Dodd‑Frank Act directs the Board to "give due regard to the principle of national treatment and equality of competitive opportunity" when applying section 165 to foreign‑based BHCs and to consider comparable home‑country standards. However, the proposals deliberately diverge from Basel where U.S. market structure, GAAP, or statutory mandates warrant—meaning host‑country rules remain determinative for IHC capital regardless of home‑country consolidation. FBOs will need to manage divergent capital stacks across jurisdictions.

Implementation Timeline for FBO IHCs

Strategic Decision Framework for FBO IHCs

A key threshold decision is whether to elect ERBA at the IHC level, requiring parallel modeling of credit, operational, market‑risk, and CVA RWA under both approaches, weighted against the irrevocable AOCI and capital‑definition checking. The estimated net
–3.0% CET1 impact for Category III–IV IHCs on the standardized approach may understate risk for IHCs with concentrated AFS/HTM securities portfolios—making AOCI phase‑in modeling against buffer usage and dividend capacity essential. Trading‑active IHCs should evaluate whether activity triggers are likely to bind and pre‑position for revised market‑risk and CVA frameworks. Covered IHCs of GSIB FBOs should recalibrate TLAC/LTD buffers and SCCL cross‑references for the new RWA definitions, and all FBOs should assess how average‑based systemic indicator reporting may shift category classifications over time.